Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
141.2 SEK | -5.80% | -4.59% | -22.63% |
Apr. 15 | Gisli Hennermark to Leave His Position as CEO of Surgical Science Sweden AB | CI |
Mar. 12 | Surgical Science Sweden to Step Down; Search for Successor Starts | MT |
Sales 2024 * | 999M 91.87M | Sales 2025 * | 1.2B 110M | Capitalization | 7.2B 662M |
---|---|---|---|---|---|
Net income 2024 * | 212M 19.49M | Net income 2025 * | 304M 27.94M | EV / Sales 2024 * | 6.35 x |
Net cash position 2024 * | 863M 79.3M | Net cash position 2025 * | 1.13B 104M | EV / Sales 2025 * | 5.07 x |
P/E ratio 2024 * |
33.9
x | P/E ratio 2025 * |
23.7
x | Employees | 260 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 73.22% |
Latest transcript on Surgical Science Sweden AB
1 day | -5.80% | ||
1 week | -4.59% | ||
Current month | -6.92% | ||
1 month | -3.29% | ||
3 months | -23.68% | ||
6 months | +13.87% | ||
Current year | -22.63% |
Managers | Title | Age | Since |
---|---|---|---|
Anders Larsson
FOU | Founder | 51 | 97-07-23 |
Gisli Hennermark
CEO | Chief Executive Officer | 52 | 14-12-31 |
Director of Finance/CFO | 54 | 17-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Roland Bengtsson
CHM | Chairman | 69 | 04-12-31 |
Director/Board Member | 57 | 16-12-31 | |
Director/Board Member | 49 | 21-05-11 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.04% | 5 M€ | +7.05% | ||
0.00% | 10 M€ | -3.35% | - | |
0.00% | 152 M€ | -3.71% | - | |
0.00% | 26 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-25 | 141.2 | -5.80% | 81,210 |
24-04-24 | 149.9 | -0.73% | 78,169 |
24-04-23 | 151 | -0.13% | 50,768 |
24-04-22 | 151.2 | +4.49% | 118,785 |
24-04-19 | 144.7 | -2.23% | 345,648 |
Delayed Quote Nasdaq Stockholm, April 25, 2024 at 11:29 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-22.63% | 702M | |
+3.41% | 32.41B | |
+12.62% | 7.31B | |
+20.38% | 3.85B | |
-14.26% | 3.33B | |
-27.90% | 1.26B | |
-34.43% | 1.12B | |
+2.01% | 932M | |
-24.21% | 864M | |
-38.47% | 863M |
- Stock Market
- Equities
- SUS Stock